Published in Am J Hematol on January 01, 1977
Copper deficiency in the preterm infant of very low birthweight. Four cases and a reference range for plasma copper. Arch Dis Child (1985) 1.25
Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol (2014) 0.99
Macrocytic anaemia due to copper deficiency in a patient with late onset hypogammaglobulinaemia. Postgrad Med J (1987) 0.95
The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens. J Biol Chem (2015) 0.92
Pancytopenia related to dental adhesive in a young patient. Am J Stem Cells (2013) 0.81
Copper modulates the differentiation of mouse hematopoietic progenitor cells in culture. Cell Transplant (2009) 0.79
Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood. Acta Naturae (2016) 0.75
Copper in parenteral nutrition. Bull N Y Acad Med (1984) 0.75
Engineering cord blood to improve engraftment after cord blood transplant. Stem Cell Investig (2017) 0.75
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med (1993) 2.90
Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol (2006) 2.79
Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol (1980) 2.15
Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med (1979) 2.06
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease. Am J Clin Pathol (1987) 1.86
Changes in serum colony-stimulating factor and monocytic progenitor cells during Listeria monocytogenes infection in mice. Infect Immun (1984) 1.70
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
Recurrence of adult Still's disease after pregnancy. J Rheumatol (1990) 1.49
Prevention of Legionella infections in a bone marrow transplant unit: multifaceted approach to decontamination of a water system. Infect Control Hosp Epidemiol (1993) 1.44
Enhancement of monocytopoiesis by granulocyte colony-stimulating factor: evidence for secondary cytokine effects in vivo. Exp Hematol (1995) 1.44
Mucin-positive epithelial mesothelioma. Arch Pathol Lab Med (1992) 1.43
Purification and properties of L cell-derived colony-stimulating factor. J Lab Clin Med (1979) 1.41
Comparative response of normal human thymus and lymph node cells to phytohemagglutinin in culture. Blood (1967) 1.40
alpha-Interferon in myelofibrosis: a case report. Br J Haematol (1994) 1.40
Immunological responsiveness of tuberculosis patients receiving rifampin. Antimicrob Agents Chemother (1974) 1.33
Amino-terminal amino acid sequence of murine colony-stimulating factor 1. Proc Natl Acad Sci U S A (1985) 1.27
Effect of prostaglandin E on immune complex nephritis in NZB/W mice. Lab Invest (1979) 1.24
The immune response to foreign red blood cells and the participation of short-lived lymphocytes. J Exp Med (1967) 1.22
Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol (1985) 1.20
Acquired immunodeficiency syndrome in the child of a haemophiliac. Lancet (1985) 1.20
Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice. Clin Immunol Immunopathol (1981) 1.18
Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci U S A (1987) 1.18
Fulminant meningococcemia and disseminated intravascular coagulation. Arch Intern Med (1969) 1.18
Natural killer cells suppress human erythroid stem cell proliferation in vitro. Blood (1984) 1.15
Effect of Listeria monocytogenes infection on serum levels of colony-stimulating factor and number of progenitor cells in immune and nonimmune mice. Infect Immun (1985) 1.15
Granulocyte colony stimulating factor. I. Response to acute granulocytopenia. Blood (1971) 1.14
Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14
Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol (1992) 1.13
Fractionation of antibodies to L-cell colony-stimulating factor by affinity chromatography. Blood (1979) 1.12
Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity. J Clin Invest (1982) 1.12
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int (1984) 1.11
Stimulatory effects of purified macrophage colony-stimulating factor on murine resident peritoneal macrophages. Cell Immunol (1986) 1.09
Mechanisms of immunosuppression: effects of cyclophosphamide on cellular immunity. Blood (1973) 1.09
Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma). Arthritis Rheum (1974) 1.07
Age- and sex-related glomerulonephritis in New Zealand white mice. Clin Immunol Immunopathol (1980) 1.07
Hematopoietic factor production by a cell line (TC-1) derived from adherent murine marrow cells. Blood (1985) 1.06
Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med (1987) 1.06
Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosus: reversal with corticosteroid therapy. Am J Hematol (1978) 1.05
In utero sensitization with influenza virus in man. Proc Soc Exp Biol Med (1975) 1.05
Augmentation of PHA responsiveness in mixed thymus-marrow cultures. J Immunol (1971) 1.04
Aplastic anemia following infectious mononucleosis: possible immune etiology. Exp Hematol (1979) 1.04
Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol (2001) 1.04
Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J Immunol (1995) 1.02
Murine bone marrow cell line producing colony-stimulating factor. Proc Natl Acad Sci U S A (1981) 1.02
Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions. Blood (1989) 1.00
Preparation and neutralization characteristics of an anti-CSF antibody. J Cell Physiol (1975) 1.00
Cellular immunity in progressive systemic sclerosis (scleroderma). Ann Rheum Dis (1972) 0.99
Differential effects of immunosuppressants on lymphocyte function. J Clin Invest (1973) 0.98
Mechanisms of immunosuppression: effect of cyclophosphamide on responses to influenza immunization. J Lab Clin Med (1974) 0.98
Cellular origin of granulocyte colonies in chronic myeloid leukaemia. Lancet (1971) 0.97
Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease. Bone Marrow Transplant (1991) 0.96
Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr (1997) 0.96
Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 0.96
Bleomycin-induced scleroderma. J Rheumatol (1981) 0.96
Microscopic platelet size and morphology in various hematologic disorders. Blood (1978) 0.96
Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome. J Immunol (1985) 0.95
Purification of colony-stimulating factor by affinity chromatography. Blood (1982) 0.95
CNS involvement as the initial manifestation of acute leukemia. Cancer (1973) 0.95
Agammaglobulinemia with polyarthritis and subcutaneous nodules. Am J Med (1970) 0.94
Fasting-enhanced immune effector mechanisms in obese subjects. Am J Med (1983) 0.94
Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen. Am J Med (1984) 0.94
Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemother Rep (1967) 0.93
Immunologic characterization of chronic lymphocytic leukemia cells. Cancer (1977) 0.92
The effect of preirradiation of recipient mice on the proliferation of transplanted hemopoietic stem cells. Blood (1971) 0.92
Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1982) 0.91
A method for the removal of endotoxin from purified colony-stimulating factor. Proc Soc Exp Biol Med (1980) 0.91
Absence of imune deficiencies in a case of progressive multifocal leukoencephalopathy. Am J Med (1976) 0.91
Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apher (2001) 0.90
The kinetics of cyclosporine and its metabolites in bone marrow transplant patients. Br J Clin Pharmacol (1991) 0.89
Cytokine expression from bone marrow derived macrophages. Exp Hematol (1993) 0.89
Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med (1985) 0.88
Dependency of human T lymphocyte colony formation on soluble factors produced by accessory or tumor cells. J Immunol (1983) 0.88
Effect of immunosuppressive drugs on T and B lymphocytes in guinea pigs. Blood (1977) 0.88
Production of colony stimulating factor in long-term bone marrow cultures. J Cell Physiol (1983) 0.88
High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. Blood (1987) 0.88
Lymphocyte subsets associated with T cell receptor beta-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis Rheum (1992) 0.87
Hematopoietic regulatory factors produced in long-term murine bone marrow cultures and the effect of in vitro irradiation. Blood (1984) 0.87
Failure of lymphocytes from guinea pig bone marrow to respond to phytohemagglutinin. Proc Soc Exp Biol Med (1971) 0.87
Physiologic distribution of colony-stimulating factor in vivo. Blood (1979) 0.87
Mechanisms of immunosuppression: effects of cyclophosphamide on lymphocytes. J Lab Clin Med (1972) 0.87
Hairy cell leukaemia: seven cases with probable B-lymphocytic origin. Br J Haematol (1977) 0.87
Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J Immunol (1992) 0.87